•  Summary 
  •  
  •  Actions 
  •  
  •  Committee Votes 
  •  
  •  Floor Votes 
  •  
  •  Memo 
  •  
  •  Text 
  •  
  •  LFIN 
  •  
  •  Chamber Video/Transcript 

A10298 Summary:

BILL NOA10298
 
SAME ASSAME AS S09136
 
SPONSORRules (Weprin)
 
COSPNSR
 
MLTSPNSR
 
Amd §6302, Ins L
 
Expands authorization for certain exemptions from filing requirements.
Go to top    

A10298 Actions:

BILL NOA10298
 
05/17/2024referred to insurance
Go to top

A10298 Memo:

NEW YORK STATE ASSEMBLY
MEMORANDUM IN SUPPORT OF LEGISLATION
submitted in accordance with Assembly Rule III, Sec 1(f)
 
BILL NUMBER: A10298
 
SPONSOR: Rules (Weprin)
  TITLE OF BILL: An act to amend the insurance law, in relation to expanding authori- zation for certain exemptions from filing requirements   PURPOSE: This bill would extend the authority for a domestic medical malpractice insurer to secure a license to use the Free Trade Zone (FTZ) and would also expand this authorization to properly allow these insurers to assume reinsurance without any limit.   SUMMARY OF PROVISIONS: Section 1 of the bill amends section 6302 (c) (3) of the insurance law to extend the authority of a domestic medical malpractice insurance company meeting the requisite surplus to policyholder ratio to write in the FTZ from June 30, 2025 to June 30, 2029. In addition, the bill would remove the current law's prohibition on a domestic medical malpractice insurer assuming reinsurance in an amount that exceeds 5 percent of such insurer's total direct premiums written.   EXISTING LAW: The current law expires on June 30, 2025.   JUSTIFICATION: In 2011, the Legislature adopted the New York ("NY") version of "commer- cial deregulation" by adding a new Class 3 as a type of risks that may be written in NY's FTZ with the Governor signing this bill into law as Chapter 490. Part of that chapter included a prohibition against medical malpractice insurers writing Class 3 risks and also substantially amended then-Insurance Law section 6302 (c) (3) to expressly codify the already-existing authority for domestic med mal insurers to write in the FTZ, provided they meet the following criteria: 1) maintain a surplus of at least twice the minimum surplus required to be maintained for the types of insurance that the med mal insurer is authorized to write in NY; 2) has total direct premiums comprised of at least 90 percent med mal insurance; 3) assume reinsurance premiums of less than 5 percent of total direct written premium; and 4) write 90 percent of its total direct premium in NY. Prior to 2011, and since 1984. NY domestic med mal insurers were author- ized to write med mal insurance in the FTZ. During all of those years, the only restriction on NY med mal insurers seeking to write med mal FTZ policies was 1 above, namely that they had to maintain the surplus of 2X the minimum required by law for their company. There was no limit regarding the type of insurance they wrote that did not consist of med mal insurance, there was no requirement that they write at least 90 percent of their total direct premium in NY and there was no prohibition on the domestic med mal insurers assuming more than 5 percent of their total direct written premium in reinsurance premiums. This bill would not affect three of the criteria listed above in order to ensure minimum financial safeguards remain in place. However, for the following reasons, the limit on the amount of reinsurance a domestic med mal insurer can assume in order to continue to write policies in the FTZ is a needless and archaic competitive hindrance for all NY domestic med mal insurers. There were only 5 MPLI insurers in 1985 (and furthermore there were no RRGs since that law was not passed until 1986), now there are approxi- mately 40 MPLI insurers with numerous RRGs vying for business with admitted carriers. Not only is the current NY MPLI market no longer small and noncompet- itive as it was from 1985 through 2011, in fact it is large, growing and extremely competitive. For example, one good indicator of an insurance market's competitiveness is its residual market, i.e., the market of last resort after a health provider is unable to obtain MPLI from an admitted company. NY's residual market for MPLI is the Medical Malprac- tice Insurance Pool ("MMIP"). The MMIP's earned premium has decreased from over $110 million to under $40 million in the last ten years. In addition, an excellent quantitative indicator of an insurance market's competitiveness is application of the US Justice Department's commonly used measure of competition in markets, the Herfindahl-Hirschman Index ("HHI"). The HHI for the NY MPLI market demonstrates that in 2007 the NY MPLI market had an HHI of 2,527 (any HHI score over 2,500 is a highly concentrated market). In 2017 the HHI score for the NY MPLI market was 1,250 (any market with a score from 0 to 1,500 is a highly competitive market). Finally, in looking at number of competitors in the NY MPLI market, in 2020 the NY MPLI market consisted of 78 admitted insurers writing MPLI and 43 RRGs writing MPLI. As for the changes in the NY Healthcare marketplace, according to the American Medical Association employed physicians were 50.2% of all patient care physicians in 2020 in the US, up from 47.4% in 2018 and 41.8% in 2012. In contrast, self-employed physicians were 44% of all patient care physicians in 2020, down from 45.9% in 2018 and 53.2% in 2012. The percentage of physicians who were independent contractors has been steady, fluctuating in the narrow band between 5% (2012) and 6.7% (2018). While these are US figures, MSSNY and other NY medical groups do not dispute that there is a large and growing trend of physi- cians becoming employed by an entity other than themselves in New York State. This trend of larger and larger hospitals and health systems consolidat- ing and self-insuring themselves and increasingly their employed physi- cians is borne out in the official numbers from the New York Department of Financial Services ("DFS") regarding NY MPLI premiums. According to the DFS Annual Reports, in 2015 NY MPLI premiums were $1.1 billion. In 2021, NY MPLI premiums were $853 million. This represents a 23 percent decline during those years and a 9 percent decline in MPLI premiums from 2017 to 2021. The rise in self-insurance is fueled in large part by the ever-increasing concentration of fewer companies in the hospital and large physician group space and increased acquisitions and mergers among health care providers. What this means for NY domestic med mal insurers such as MLMIC and others is that opportunities to insure individual physicians is shrink- ing but the need of these large hospitals and health systems/large physician groups for reinsurance is growing. Sound NY public policy would dictate that NY domestic insurers should not be disadvantaged from competing for these reinsurance opportunities due to an arbitrary limit on the amount of reinsurance they can write in order to also write in the FTZ. The other restrictions in the current law, especially the requirement that any such domestic med mal insurer must maintain a surplus of at least 2X the minimum legally required surplus, will fully and more than adequately provide solvency and fiscal safeguards for these insurers and their customers. This proposal merely levels the playing field for NY domestic med mal insurers.   LEGISLATIVE HISTORY: New bill.   FISCAL IMPLICATIONS: None   EFFECTIVE DATE: Immediately.
Go to top

A10298 Text:



 
                STATE OF NEW YORK
        ________________________________________________________________________
 
                                          10298
 
                   IN ASSEMBLY
 
                                      May 17, 2024
                                       ___________
 
        Introduced  by  COMMITTEE ON RULES -- (at request of M. of A. Weprin) --
          read once and referred to the Committee on Insurance
 
        AN ACT to amend the insurance law, in  relation  to  expanding  authori-
          zation for certain exemptions from filing requirements
 
          The  People of the State of New York, represented in Senate and Assem-
        bly, do enact as follows:

     1    Section 1. Paragraph 3 of subsection (c) of section 6302 of the insur-
     2  ance law, as amended by chapter 158 of the laws of 2023, is  amended  to
     3  read as follows:
     4    (3)  until  June  thirtieth, two thousand [twenty-five] twenty-nine, a
     5  domestic property/casualty insurance company that maintains at all times
     6  a surplus to policyholders of at least  twice  the  minimum  surplus  to
     7  policyholders  required to be maintained for the kinds of insurance that
     8  it is authorized to write in this state, or an insurer licensed pursuant
     9  to article sixty-one of this chapter as a reciprocal insurer that  main-
    10  tains  at  all  times a surplus to policyholders of at least the minimum
    11  surplus to policyholders required to be  maintained  for  the  kinds  of
    12  insurance  that  it  is authorized to write in this state, provided that
    13  the domestic property/casualty insurance company or reciprocal  insurer:
    14  (A)  has  total  direct  premiums  comprised  of at least ninety percent
    15  medical malpractice insurance; [(B) assumes reinsurance premiums  in  an
    16  amount that is less than five percent of total direct premiums written;]
    17  and [(C)] (B) writes ninety percent of its total direct premiums in this
    18  state.
    19    § 2. This act shall take effect immediately.
 
 
 
 
         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD15275-01-4
Go to top